Returns On Capital Signal Tricky Times Ahead For ShuYu Civilian Pharmacy (SZSE:301017)
Dec 19
Have your own idea? Try our Stock Screener
Chinese (SSE) Drug Retail Industry Analysis
UpdatedDec 22, 2024
DataAggregated Company Financials
Companies9
- 7D-1.7%
- 3M34.0%
- 1Y-24.7%
- YTDn/a
Over the last 7 days, the Drug Retail industry has dropped 4.3%, driven by LBX Pharmacy Chain declining 6.8%. Overall the industry is down 26% in 12 months. Looking forward, earnings are forecast to grow by 23% annually.
Industry Valuation and Performance
Has the Chinese Drug Retail Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 22 Dec 2024 | CN¥92.7b | CN¥121.0b | CN¥3.9b | 21.3x | 23.7x | 0.8x |
| Tue, 19 Nov 2024 | CN¥89.3b | CN¥121.0b | CN¥3.9b | 20.3x | 22.9x | 0.7x |
| Thu, 17 Oct 2024 | CN¥80.7b | CN¥119.6b | CN¥4.3b | 18.1x | 18.7x | 0.7x |
| Sat, 14 Sep 2024 | CN¥66.6b | CN¥119.6b | CN¥4.3b | 15.3x | 15.4x | 0.6x |
| Mon, 12 Aug 2024 | CN¥75.7b | CN¥118.4b | CN¥4.8b | 17.8x | 15.8x | 0.6x |
| Wed, 10 Jul 2024 | CN¥81.1b | CN¥118.4b | CN¥4.8b | 19.3x | 16.9x | 0.7x |
| Fri, 07 Jun 2024 | CN¥116.0b | CN¥118.4b | CN¥4.8b | 24.2x | 24.2x | 1x |
| Sun, 05 May 2024 | CN¥122.3b | CN¥117.4b | CN¥4.8b | 26.1x | 25.6x | 1x |
| Tue, 02 Apr 2024 | CN¥115.5b | CN¥114.8b | CN¥5.2b | 21.2x | 22.1x | 1x |
| Thu, 29 Feb 2024 | CN¥116.5b | CN¥115.9b | CN¥5.8b | 21x | 20x | 1x |
| Sat, 27 Jan 2024 | CN¥119.4b | CN¥116.0b | CN¥5.7b | 21x | 20.8x | 1x |
| Mon, 25 Dec 2023 | CN¥123.3b | CN¥116.0b | CN¥5.7b | 21.8x | 21.5x | 1.1x |
| Wed, 22 Nov 2023 | CN¥128.4b | CN¥116.0b | CN¥5.7b | 22.7x | 22.4x | 1.1x |
| Fri, 20 Oct 2023 | CN¥111.2b | CN¥113.6b | CN¥5.7b | 21.4x | 19.6x | 1x |
| Sun, 17 Sep 2023 | CN¥121.1b | CN¥113.6b | CN¥5.7b | 23.8x | 21.3x | 1.1x |
| Tue, 15 Aug 2023 | CN¥134.2b | CN¥109.7b | CN¥5.4b | 29x | 24.7x | 1.2x |
| Thu, 13 Jul 2023 | CN¥127.9b | CN¥109.7b | CN¥5.4b | 27.2x | 23.5x | 1.2x |
| Sat, 10 Jun 2023 | CN¥127.9b | CN¥109.7b | CN¥5.4b | 26.4x | 23.5x | 1.2x |
| Mon, 08 May 2023 | CN¥137.0b | CN¥109.2b | CN¥5.4b | 28.4x | 25.3x | 1.3x |
| Wed, 05 Apr 2023 | CN¥144.7b | CN¥94.8b | CN¥4.4b | 38.4x | 33.2x | 1.5x |
| Fri, 03 Mar 2023 | CN¥143.2b | CN¥90.3b | CN¥4.0b | 35.5x | 35.6x | 1.6x |
| Sun, 29 Jan 2023 | CN¥144.2b | CN¥90.3b | CN¥4.0b | 37x | 35.8x | 1.6x |
| Tue, 27 Dec 2022 | CN¥139.6b | CN¥90.3b | CN¥4.0b | 35.5x | 34.7x | 1.5x |
| Thu, 24 Nov 2022 | CN¥146.7b | CN¥90.3b | CN¥4.0b | 37.3x | 36.4x | 1.6x |
| Sat, 22 Oct 2022 | CN¥129.1b | CN¥85.6b | CN¥3.8b | 40.5x | 33.8x | 1.5x |
| Mon, 19 Sep 2022 | CN¥111.8b | CN¥85.6b | CN¥3.8b | 35.2x | 29.3x | 1.3x |
| Wed, 17 Aug 2022 | CN¥113.6b | CN¥80.8b | CN¥3.7b | 36.1x | 30.5x | 1.4x |
| Fri, 15 Jul 2022 | CN¥116.5b | CN¥80.8b | CN¥3.7b | 38.4x | 31.2x | 1.4x |
| Sun, 12 Jun 2022 | CN¥107.3b | CN¥80.8b | CN¥3.7b | 34.4x | 28.8x | 1.3x |
| Tue, 10 May 2022 | CN¥95.6b | CN¥80.8b | CN¥3.7b | 29.5x | 25.6x | 1.2x |
| Thu, 07 Apr 2022 | CN¥100.3b | CN¥75.3b | CN¥4.1b | 27.7x | 24.7x | 1.3x |
| Sat, 05 Mar 2022 | CN¥119.1b | CN¥74.7b | CN¥4.1b | 33.6x | 29.2x | 1.6x |
| Mon, 31 Jan 2022 | CN¥118.6b | CN¥74.7b | CN¥4.1b | 34.3x | 29.1x | 1.6x |
| Wed, 29 Dec 2021 | CN¥135.0b | CN¥74.7b | CN¥4.1b | 37.9x | 33.1x | 1.8x |
Price to Earnings Ratio
33.1x
Current Industry PE
- Investors are pessimistic on the Chinese Drug Retail industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 23.5x which is lower than its 3-year average PE of 26.1x.
- The 3-year average PS ratio of 1.2x is higher than the industry's current PS ratio of 0.76x.
Past Earnings Growth
- The earnings for companies in the Drug Retail industry have remained mostly flat over the last three years.
- Meanwhile revenues for these companies have grown 17% per year.
- This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.
Industry Comparison
How does Chinese Drug Retail compare with similar industries?
| CN Market | -1.18% | |
| Consumer Staples | -2.52% | |
| Food and Staples Retail | -6.29% | |
| Drug Retail | -1.69% | |
| Big Box Super Stores | -2.38% | |
| Food Distributors | -8.47% | |
| Food Retail | -9.26% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 603939 Yifeng Pharmacy Chain | CN¥25.90 | 4.1% +CN¥1.2b | -17.1% | PE20.6x | |
| 603233 DaShenLin Pharmaceutical Group | CN¥16.45 | 1.4% +CN¥261.9m | -33.3% | PE22x |
